InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,996.20
(
0.39%
)
US TECH 100
20,552.00
(
0.05%
)
Dow Jones
43,992.89
(
0.60%
)
Brent Oil
73.93
(
-2.03%
)
Bitcoin
76,484.03
(
0.77%
)
Post# of 253557
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120694
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: microcapfun post# 55503

Sunday, 12/02/2007 3:22:02 AM

Sunday, December 02, 2007 3:22:02 AM

Post# of 253557
>ONXX – How does having a small molecule drug help in the case of macular degeneration? You don't want to treat MD systemically, do you??<

No, you do not. The last company to try a systemic treatment for AMD was GENR, and the program was terminated for lack of enrollment.

Nexavar would presumably have to be modified to increase the half-life if it were to become a serious candidate for treatment of AMD via intravitreal injection.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up